Drug Channels Archive for April, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-04-30 07:06Drug Channels - My Wall Street Journal Op-Ed: Don't Blame Drug Prices on 'Big Pharma' (rerun)
2019-04-29 07:28Drug Channels - Financial Strategies and Accounting for Bioscience Companies
2019-04-26 07:41Drug Channels - Help for the Patient Journey–Electronic Modernization of Medication Access
2019-04-25 07:39Drug Channels News Roundup, April 2019: Cigna's Insulin Program, Amazon's PillPack Moves, Magellan's Biosimilar Success, Prime's Formulary Exclusions, and a World Without Rebates
2019-04-23 07:59Drug Channels - The Specialty Pharmacy Boom: Our Exclusive Update on the U.S. Market
2019-04-22 08:03Drug Channels - CBI's 15th Annual Commercial Contract & Chargeback Excellence
2019-04-18 07:38Drug Channels - TrialCard: The Role of Hub Services in an Era of Drug Price Transparency, Value-Based Care, and Consumerism
2019-04-16 07:43Drug Channels - The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform
2019-04-15 07:35Drug Channels - Rare Disease Innovation and Partnering Summit
2019-04-12 07:45Drug Channels - Drug Price Transparency and Rebate Reform Take Center Stage
2019-04-10 07:36This Friday: Preparing for a World Without Rebates
2019-04-09 07:46Drug Channels - The Top 15 Specialty Pharmacies of 2018: PBMs Keep Winning
2019-04-08 07:35Drug Channels - World Congress' Integrate 2019
2019-04-05 07:23Drug Channels - Addressing the Rising Impact of Co-Pay Accumulators on Patients
2019-04-03 07:36Drug Channels - The Gross-to-Net Bubble Reached a Record $166 Billion in 2018
2019-04-01 07:44Drug Channels - Preparing for a World Without Rebates: A Drug Channels Institute Webinar


<< Archive IndexSubscribe >>